Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | XIAP | P98170 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29437136 | 1.00 | MAPT (0.41) | MAPTHTTPOLBTSHRHSD17B10 | |
| SCHEMBL13064249 | 0.91 | TSHR (0.50) | MAPTHTTPOLBTSHRHSD17B10 | |
| SCHEMBL13210721 | 0.90 | NTRK1 (0.43) | MAPTHTTPOLBTSHRHSD17B10 | |
| SCHEMBL1044642 | 0.90 | MAPT (0.45) | MAPTHTTPOLBTSHRHSD17B10 | |
| SCHEMBL13210713 | 0.89 | MAPT (0.41) | MAPTHTTPOLBTSHRHSD17B10 | |
| SCHEMBL343339 | 0.89 | TDP1 (0.47) | MAPTHTTPOLBTSHRHSD17B10 | |
| SCHEMBL121792 | 0.87 | ABCG2 (0.47) | MAPTHTTPOLBTSHRHSD17B10 | |
| SCHEMBL29419103 | 0.87 | ABCG2 (0.47) | MAPTHTTPOLBTSHRHSD17B10 | |
| SCHEMBL13210812 | 0.87 | MAPT (0.40) | MAPTHTTPOLBTSHRHSD17B10 | |
| SCHEMBL20514734 | 0.87 | ALDH1A1 (0.41) | MAPTHTTPOLBTSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 887 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12163142-B2 | Methods for manufacturing plant messenger packs | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2024-12-10 | — | — | US | claimed |
| US-11827897-B2 | Agricultural compositions and related methods | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2023-11-28 | — | — | US | claimed |
| US-20220064661-A1 | AGRICULTURAL COMPOSITIONS AND RELATED METHODS | FLAGSHIP PIONEERING INNOVATIONS VI, LLC | 2022-03-03 | — | — | US | claimed |
| EP-3954214-A1 | MULTIPURPOSE BIOLOGICAL COMPOSITIONS | Agrivalle Brasil Industria e Comércio de Produtos Agrícolas Ltda (BR) | 2022-02-16 | — | — | EP | claimed |
| EP-3381289-B1 | COMBINATIONS COMPRISING A FUNGICIDAL STRAIN AND AN ACTIVE COMPOUND | BAYER CROPSCIENCE LP (US) | 2021-05-05 | — | — | EP | claimed |
| WO-2020206518-A1 | MULTIPURPOSE BIOLOGICAL COMPOSITIONS | AGRIVALLE BRASIL INDUSTRIA E COMÉRCIO DE PRODUTOS AGRÍCOLAS LTDA (BR) | 2020-10-15 | — | — | WO | claimed |
| EP-2292098-B1 | Combinations comprising a fungicidal strain and at least one additional fungicide | BAYER CROPSCIENCE LP (US) | 2019-11-06 | — | — | EP | claimed |
| EP-3510869-A1 | COMBINATIONS COMPRISING A FUNGICIDAL STRAIN AND AN ACTIVE COMPOUND | Bayer Cropscience LP (US) | 2019-07-17 | — | — | EP | claimed |
| EP-2489262-B1 | PESTICIDAL MIXTURES COMPRISING AN ANTHRANILAMIDE INSECTICIDE AND A FUNGICIDE | BASF SE (DE) | 2018-11-14 | — | — | EP | claimed |
| EP-3381289-A1 | COMBINATIONS COMPRISING A FUNGICIDAL STRAIN AND AN ACTIVE COMPOUND | Bayer Cropscience LP (US) | 2018-10-03 | — | — | EP | claimed |
| WO-2008034785-A2 | PESTICIDAL MIXTURES COMPRISING AN ANTHRANILAMIDE INSECTICIDE AND A FUNGICIDE | BASF SE (DE) | 2008-03-27 | — | — | WO | claimed |
| WO-2008034787-A2 | PESTICIDAL MIXTURES COMPRISING AN ANTHRANILAMIDE INSECTICIDE AND A FUNGICIDE | BASF SE (DE) | 2008-03-27 | — | — | WO | claimed |
| EP-1819223-B1 | USE OF MENADIONE FOR BOOSTING THE EFFECTIVENESS OF AGROCHEMICALS | BASF SE (DE) | 2008-03-12 | — | — | EP | claimed |
| US-20080039320-A1 | Use Of Menadione | BASF AKTIENGESELLSCHAFT (DE) | 2008-02-14 | — | — | US | claimed |
| WO-2007122264-A2 | COMPOSITION COMPRISING A GLUCAN OR A GLUCAN DERIVATIVE AND A PESTICIDE AND METHODS FOR IMPROVING PLANT HEALTH | BASF SE (DE) | 2007-11-01 | — | — | WO | claimed |
| EP-1849364-A1 | Composition comprising a glucan or a glucan derivative and a pesticide and methods for improving plant health | BASF AKTIENGESELLSCHAFT (DE) | 2007-10-31 | — | — | EP | claimed |
| WO-2007104669-A2 | METHOD OF INDUCING VIRUS TOLERANCE OF PLANTS | BASF SE (DE) | 2007-09-20 | — | — | WO | claimed |
| WO-2007104658-A2 | METHOD OF INDUCING TOLERANCE OF PLANTS AGAINST BACTERIOSES | BASF SE (DE) | 2007-09-20 | — | — | WO | claimed |
| WO-2007101547-A2 | SYNERGISTIC COMBINATIONS OF ACTIVE INGREDIENTS | BAYER CROPSCIENCE AG (DE) | 2007-09-13 | — | — | WO | claimed |
| US-20070060579-A1 | Synergistic fungicidal active substance combinations | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2007-03-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080039320-A1 | Use Of Menadione | MANBA, MGAM2, MGAM | MAPT 4216/4885HTT 4804/4885POLB 1094/4885 |
| US-20070060579-A1 | Synergistic fungicidal active substance combinations | CYP51A1, CYP1A2, CYP4X1 | MAPT 4345/4885HTT 4694/4885POLB 3814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.